Begin main content

Botulinum Toxin A for Spasticity and Associated Pain Following Damage to the Central Nervous System: Clinical and Cost-Effectiveness and Guidelines for Use

Last updated: May 28, 2008
Product Line: Rapid Response
Research Type: Drug
Result type: Report

Question

  1. What is the clinical effectiveness of botulinum toxin A for the management of spasticity and associated pain following damage to the central nervous system?
  2. What is the cost-effectiveness of botulinum toxin A for the management of spasticity and associated pain following damage to the central nervous system?
  3. What are the guidelines for use of botulinum toxin A in clinical practice for the management of spasticity and associated pain following damage to the central nervous system?